Clinical Trials associated with Inner Mongolia Shuangqi Pharmaceutical Co. Ltd.
ChiCTR2100044914
/ RecruitingPhase 4IIT
A Multi-center, Randomized, Controlled Trial: Live Combined Bifidobacterium and Lactobacillus Triplex Viable Tablets in Antibiotic-associdated Diarrhea in Children
Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
Author: Ning, Kang ; Liao, Feng ; Chang, Longgang ; Chen, Zhangran ; Wang, Min ; Liu, Yanmin ; Chen, Jinmiao ; Zhao, Ming ; Zhao, Xiaoxiao ; Wu, Qinglong
A review.This current Research Topic brings nine articles together presenting and summarizing the most recent research updates, which give us a better understanding of new potential diagnostics and therapeutics for some ADs.
100 Deals associated with Inner Mongolia Shuangqi Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Inner Mongolia Shuangqi Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!